Influence of Insulin Resistance and Adipocytokines on Elevated Serum Alanine Aminotransferase in Obese Patients

Archives of Medical Research

Volumn 39, Issue 1, 2008, Pages 110-114

  de Luis, Daniel Antonio ^a   Aller, Rocio ^a   Izaola, Olatz ^a   Sagrado, Manuel Gonzalez ^a   Conde, Rosa ^a   Bellido, Diego ^a  

^a Medical School   (Spain)

Author keywords

Adipocytokines; Alanine aminotransferase; Insulin resistance; Nonalcoholic fatty liver disease; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; INSULIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OBESITY; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE;

ADIPOKINES; ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MIDDLE AGED; OBESITY;

EID: 36749086999     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.06.009     Document Type: Article

References (23)

1. Ludwig J., Viggiano T.R., McGill D.B., and Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiencies with a hitherto unnamed disease. Mayo Clinic Proc 55 (1980) 434-438
2. Kral J.G., Schaffner F., Pierson R.N., and Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism 42 (1993) 548-551
3. Chitturi S., Abeygunasekera S., Farell G.C., Holmes-Walker J., Hui M., Fung C., Karim R., and NASH. insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
4. Marceau P., Biron S., Hould F.S., Marceau S., Simard S., Thung S.N., and Kral J.G. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84 (1999) 1513-1517
5. Kumada M., Kihara S., and Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
6. Shimomura I., Hammer R.E., and Ikemoto S. Leptin reverses insulin resitance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401 (1999) 73-76
7. Steppan C.M., Bailey S.T., and Bhat S. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
8. Matsuzawa Y. Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep 7 (2005) 58-62
9. Vosarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., and Bogardus C. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
10. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., and Treacher D.F. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-414
11. Pichard C., Slosman D., Hirschel B., and Kyle U. Bioimpedance analysis in patients: an improved method for nutritional follow up. Clin Res 41 (1993) 53
12. Mataix J., and Mañas M. Tablas de composición de alimentos españoles (2003), University of Granada, Granada, Spain
13. Marchesini G., Brizi M., Morselli-Labate A., Bianchi G., Bugianesi E., and McCullough A.J. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107 (1999) 450-454
14. Sanyal A.J., Campbell Sargent C., Mirshashi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitocohondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
15. Rashid M., and Roberts E.A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30 (2000) 48-53
16. Venturi C., Zoppini G., Zamboni C., and Muggeo M. Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance. Nutr Metab Cardiovasc Dis 14 (2004) 200-204
17. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 (2004) 147-152
18. Yesilova Z., Ozata M., Oktenli C., Bagci S., and Ozcan A. Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance. Am J Gastroenterol 100 (2005) 842-849
19. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., and Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. J Clin Invest 112 (2003) 91-100
20. Lee D.H., Ha H.M., Kim J.H., Christiani D.C., Gross M.D., Steffes M., et al. Gamma glutamyltransferase and diabetes-a year follow up study. Diabetologia 46 (2003) 359-364
21. Pagano C., Soardoo G., Esposito W., Fallo F., Basan L., Donnini D., et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 152 (2005) 113-118
22. Chalasani N., Crabb D.W., Cummings O.X., Kwo P.Y., Asghar A., and Pandya P.K. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?. Am J Gastroenterol 98 (2003) 2771-2776
23. Kazumi T., Kawaguchi A., Hirano T., and Yoshino G. Serum alanine aminotransferase is associated with serum adiponectin, C reactive protein and apolipoprotein B in young healthy men. Hormone Res Metab 38 (2006) 119-124